26 May 2017 | 1:41 PM
 

Dr. Lal Pathlabs Ltd. Share Price Live (BSE)
0

BSE Code: 539524 | NSE Symbol: LALPATHLAB
899.25
4.55
(0.51 %)
26 May 2017 | 01:31 PM
Change company
  • Open (Rs)
    900.00
  • Prev. close (Rs.)
    894.70
  • High (Rs.)
    908.00
  • Low (Rs.)
    899.00
  • 52W H (Rs.)
    1,278.55
  • 52W L (Rs.)
    792.50
  • Volume (Rs.)
    1522
  • MCap (Rs in Cr.)
    7,469.72
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
15.99
Operating Margin (%)
26.50
Gross Profit Margin (%)
22.92
Net Profit Margin (%)
16.70
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
18.59
Earning Retention Ratio
81.56

News

02 Mar 2017 - 12:42:00-Westbridge Crossover sold 1...
02 Mar 2017 - 12:32:00-Westbridge Crossover has sold 1...
02 Feb 2017 - 15:00:00-Dr...
29 Jul 2016 - 16:27:00-Healthcare firm Dr Lal PathLabs Ltd on Friday registered a surge of 29...

Announcements

23-May-2017
Dr. Lal Pathlabs Ltd - Intimation Of Schedule Of Analyst/ Institutional Investor Meetings Pursuant To Regulation 30 Of Securi
19-May-2017
Dr. Lal Pathlabs Ltd - Disclosure Of Information Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement)
18-May-2017
Dr. Lal Pathlabs Ltd - Intimation Of Schedule Of Analyst/ Institutional Investor Meetings Pursuant To Regulation 30 Of Securi
17-May-2017
Dr. Lal Pathlabs Ltd - Allotment Of 266560 Shares Under ESOP 2010 Plan Of The Company
15-May-2017
Dr. Lal Pathlabs Ltd - Intimation Of Schedule Of Analyst/ Institutional Investor Meetings Pursuant To Regulation 30 Of Securi

Religare Research

25 May 2017 | 11:21 AM
SML Isuzu reported in-line Q4FY17 revenue growth; however Net profit took a hit due to BSIV implemen...
25 May 2017 | 10:58 AM
Agri Fundamental and Technical report
25 May 2017 | 10:09 AM
The Indian rupee rose against the dollar as banks sold the greenback in thin volume trade, even as t...
25 May 2017 | 09:31 AM
• Gold up after Fed minutes suggest little change in U.S. rate outlook • Crude futures settle lower ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors58.22%
Mutual Funds/UTI6.00%
FI/Banks0.42%
Insurance0.42%
FII10.00%
Government0.00%
Others20.24%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
4,115.00(0.33)
3280
 Sanofi India Ltd.
4,026.00(-0.77)
3325
 Pfizer Ltd.
1,666.25(-0.78)
3370
 Strides Shasun Ltd.
924.50(2.99)
13158

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Dr. Lal Pathlabs Ltd.-62.35-74.30-268.95
NIFTY(S&P CNX)281.65691.551,473.95
BSE SENSEX1,019.022,149.384,645.92
BSE 500143.53949.142,120.93

Corporate Details

Key Personal
Arvind Lal
Chairman & Managing Director
Naveen Wadhera
Non Exe. & Nominee Director
Om Prakash Manchanda
WholeTime Director & CEO
Key Address
Registered Office
Block E Sector 18 Rohini,New Delhi,Delhi

Tel:011-30244199, Fax:011-27882134

cs@lalpathlabs.com
https://www.lalpathlabs.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :506 - 508 5th Floor Amaranth Business Complex I (ABC - I) Beside Gala Business Center Nr. St. Xaviers Corner Off C. G. Road Navrangpura

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Dr. Lal Pathlabs Ltd. that will help you decide whether to buy, sell or hold Dr. Lal Pathlabs Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Dr. Lal Pathlabs Ltd.